Drug Shortage Report for LONITEN 2.5MG
| Report ID | 174141 |
| Drug Identification Number | 00514497 |
| Brand name | LONITEN 2.5MG |
| Common or Proper name | LONITEN |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MINOXIDIL |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1x100 PBTL |
| ATC code | C02DC |
| ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-08-18 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2022-11-09 |
| Company comments | Available inventory is on preventive allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-11-09 | French | Compare |
| v1 | 2022-11-09 | English | Compare |
Showing 1 to 2 of 2